HIGHFDA DEVICE

Medtronic MiniMed 780G Insulin Pump Recalled for 453,144 Units Worldwide (2026)

Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
February 13, 2026
Status
ACTIVE
Severity
9/10

Quick Facts at a Glance

Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Medtronic MiniMed
Product type
Insulin Pump
Model numbers
MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    February 13, 2026

  2. Reported by FDA DEVICE

    April 8, 2026

  3. RecallRadar source check

    April 15, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

The MiniMed 780G insulin pump automates insulin delivery for people with diabetes. It integrates with continuous glucose monitors to modulate insulin dosing.

Why This Is Dangerous

The recall cites gravity-related pressure changes that alter insulin delivery as the pump height relative to the infusion site changes. Over-delivery risks hypoglycemia; under-delivery risks hyperglycemia and ketoacidosis.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Users may experience dangerous glucose fluctuations. Notification was by letter to device owners.

Practical Guidance

How to identify if yours is affected

  1. Check model numbers MMT-1884 to MMT-1896
  2. Determine if you own a MiniMed infusion pump from the Paradigm, 600, or BLE 700 series
  3. Compare your device to the recalled product descriptions

Where to find product info

Recall letter, FDA enforcement page, and Medtronic’s recall information site

What timeline to expect

No specific timeline provided for refunds or replacements. Follow manufacturer instructions.

If the manufacturer is unresponsive

  • Document all contact attempts with Medtronic.
  • Consult your clinician if Medtronic is unresponsive.
  • Consider reporting to consumer safety authorities if needed.

How to prevent similar issues

  • Verify device compatibility with your insulin regimen.
  • Stay in touch with your healthcare provider during recalls.
  • Keep all recall communications and documentation for records.

Documentation advice

Save recall notices, model numbers, and any correspondence. Take photos of the device and packaging for records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896. Sold worldwide; US distribution across all states and territories. Price: Unknown. Sold date: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 453,144 units recalled worldwide
  • Hazard: unintended insulin delivery due to pump height changes
  • Risk: severe hypoglycemia or hyperglycemia, including coma or death
  • No injuries or incidents reported
  • Stop using the product and follow recall instructions

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
9/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
MMT-1884
MMT-1885
MMT-1886
MMT-1894
MMT-1895
+1 more
Affected States
ALL
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls